CAR-T Immunotherapy Clears Psoriasis: A 92.6% PASI Drop
Anti-CD19 CAR-T therapy given for lymphoma produced a 92.6% PASI reduction in a 45-year plaque psoriasis case, fueling review of CAR strategies for immune reset.
Topic
Car T
Topic
Topic
Topic
Anti-CD19 CAR-T therapy given for lymphoma produced a 92.6% PASI reduction in a 45-year plaque psoriasis case, fueling review of CAR strategies for immune reset.